← Back to headlines
Eli Lilly Expands Pipeline with Clazakizumab Agreement
Eli Lilly (LLY) is reportedly expanding its pharmaceutical pipeline through a new agreement involving Clazakizumab, as reported by Reuters.
20 Feb, 23:34 — 20 Feb, 23:34
ℹOnly 1 source covers this story
